Five Cases of Onychatrophy Following Bleomycin Intralesional Injections for Periungual Warts / 대한피부과학회지
Korean Journal of Dermatology
; : 262-265, 2012.
Article
em Ko
| WPRIM
| ID: wpr-75754
Biblioteca responsável:
WPRO
ABSTRACT
Onychatrophy is the processes in which the nail has initially formed satisfactorily and then shows total or partial regression. The causes of onychatrophy with pterygium include lichen planus, acrosclerosis, Stevens-Johnson syndrome, and cicatrical pemphigoid, and those without pterygium include severe paronychia, Stevens-Johnson syndrome, epidermolysis bullosa, and drugs. Bleomycin is an antitumor, antibacterial, and antiviral agent used in many dermatologic diseases such as warts, vascular anomalies, hemangioma, and cutaneous malignancies. Cutaneous adverse effects of bleomycin strongly depend on the route of administration and dosage. Bleomycin intralesional injection for periungual warts could result in permanent Raynaud phenomenon, nail dystrophy, and nail loss. We report five cases of onychatrophy following bleomycin intralesional injections for periungual warts. We remind that if bleomycin intralesional injection near the nail matrix is inevitable in recalcitrant periungual warts, the performer must manipulate precisely to avoid adverse effects.
Palavras-chave
Texto completo:
1
Base de dados:
WPRIM
Assunto principal:
Paroniquia
/
Doença de Raynaud
/
Bleomicina
/
Pterígio
/
Verrugas
/
Injeções Intralesionais
/
Epidermólise Bolhosa
/
Penfigoide Bolhoso
/
Síndrome de Stevens-Johnson
/
Hemangioma
Idioma:
Ko
Revista:
Korean Journal of Dermatology
Ano de publicação:
2012
Tipo de documento:
Article